These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 32347571)
1. RhoJ integrates attractive and repulsive cues in directional migration of endothelial cells. Fukushima Y; Nishiyama K; Kataoka H; Fruttiger M; Fukuhara S; Nishida K; Mochizuki N; Kurihara H; Nishikawa SI; Uemura A EMBO J; 2020 Jun; 39(12):e102930. PubMed ID: 32347571 [TBL] [Abstract][Full Text] [Related]
2. Rho GTPases in Retinal Vascular Diseases. Uemura A; Fukushima Y Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916163 [TBL] [Abstract][Full Text] [Related]
3. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. Fukushima Y; Okada M; Kataoka H; Hirashima M; Yoshida Y; Mann F; Gomi F; Nishida K; Nishikawa S; Uemura A J Clin Invest; 2011 May; 121(5):1974-85. PubMed ID: 21505259 [TBL] [Abstract][Full Text] [Related]
4. RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways. Wang M; Zhang C; Zheng Q; Ma Z; Qi M; Di G; Ling S; Xu H; Qi B; Yao C; Xia H; Jiang X Int J Biol Sci; 2022; 18(3):942-955. PubMed ID: 35173528 [TBL] [Abstract][Full Text] [Related]
5. RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers. Kaur S; Leszczynska K; Abraham S; Scarcia M; Hiltbrunner S; Marshall CJ; Mavria G; Bicknell R; Heath VL Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):657-64. PubMed ID: 21148427 [TBL] [Abstract][Full Text] [Related]
6. RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Yuan L; Sacharidou A; Stratman AN; Le Bras A; Zwiers PJ; Spokes K; Bhasin M; Shih SC; Nagy JA; Molema G; Aird WC; Davis GE; Oettgen P Blood; 2011 Jul; 118(4):1145-53. PubMed ID: 21628409 [TBL] [Abstract][Full Text] [Related]
7. The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling. Chintala H; Krupska I; Yan L; Lau L; Grant M; Chaqour B Development; 2015 Jul; 142(13):2364-74. PubMed ID: 26002917 [TBL] [Abstract][Full Text] [Related]
8. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687 [TBL] [Abstract][Full Text] [Related]
9. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
10. Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke. Zhou YF; Chen AQ; Wu JH; Mao L; Xia YP; Jin HJ; He QW; Miao QR; Yue ZY; Liu XL; Huang M; Li YN; Hu B FASEB J; 2019 Apr; 33(4):4947-4961. PubMed ID: 30653356 [TBL] [Abstract][Full Text] [Related]
11. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085 [TBL] [Abstract][Full Text] [Related]
12. [RhoJ signaling pathway in retinal angiogenesis: promising targets for novel anti-angiogenic therapy]. Fukushima Y Nippon Ganka Gakkai Zasshi; 2013 Nov; 117(11):903-10. PubMed ID: 24397187 [TBL] [Abstract][Full Text] [Related]
13. Molecular controls of lymphatic VEGFR3 signaling. Deng Y; Zhang X; Simons M Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775 [TBL] [Abstract][Full Text] [Related]
14. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation. Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908 [TBL] [Abstract][Full Text] [Related]
15. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010 [TBL] [Abstract][Full Text] [Related]
16. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. Huang SW; Lien JC; Kuo SC; Huang TF Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319 [TBL] [Abstract][Full Text] [Related]
17. Rab13-dependent trafficking of RhoA is required for directional migration and angiogenesis. Wu C; Agrawal S; Vasanji A; Drazba J; Sarkaria S; Xie J; Welch CM; Liu M; Anand-Apte B; Horowitz A J Biol Chem; 2011 Jul; 286(26):23511-20. PubMed ID: 21543326 [TBL] [Abstract][Full Text] [Related]
18. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways. Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896 [TBL] [Abstract][Full Text] [Related]
19. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration. Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461 [TBL] [Abstract][Full Text] [Related]
20. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling. Farhan MA; Azad AK; Touret N; Murray AG Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]